These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3228592)

  • 21. Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer.
    Chang JC; Wergowske G
    Cancer; 1981 Dec; 48(11):2503-6. PubMed ID: 7296498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of estrogen and progesterone receptors to prognosis in breast cancer.
    Gelbfish GA; Davidson AL; Kopel S; Schreibman B; Gelbfish JS; Degenshein GA; Herz BL; Cunningham JN
    Ann Surg; 1988 Jan; 207(1):75-9. PubMed ID: 3337566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
    Cherubini M; Baxa P; Guarino G
    Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Demonstration of the effect of estrogen and progesterone receptors on survival in breast cancer without cytostatic and hormonal treatment in a small set of patients].
    Hochmann J
    Klin Onkol; 2010; 23(1):25-33. PubMed ID: 20192071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of hormone receptors in the management of breast cancer--I. Advanced breast cancer.
    Cant EM; Horsfall D; Keightley DD
    Aust N Z J Surg; 1985 Apr; 55(2):121-5. PubMed ID: 3862384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.
    Valavaara R; Tuominen J; Johansson R
    Cancer; 1990 Dec; 66(11):2264-9. PubMed ID: 2147123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.
    Williams G; Howell A; Jones M
    Br J Cancer; 1988 Nov; 58(5):631-4. PubMed ID: 3219275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
    Raabe NK; Hagen S; Haug E; Fossaa SD
    Int J Oncol; 1998 May; 12(5):1091-6. PubMed ID: 9538134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
    Luoh SW; Ramsey B; Park B; Keenan E
    Breast J; 2014; 20(1):46-52. PubMed ID: 24261828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival patterns in hormone treated advanced breast cancer.
    Williams MR; Todd JH; Nicholson RI; Elston CW; Blamey RW; Griffiths K
    Br J Surg; 1986 Sep; 73(9):752-5. PubMed ID: 3756443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
    Rivkin SE; Green S; O'Sullivan J; Cruz AB; Abeloff MD; Jewell WR; Costanzi JJ; Farrar WB; Osborne CK
    J Clin Oncol; 1996 Jan; 14(1):46-51. PubMed ID: 8558219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer.
    Huang R; Han J; Liang X; Sun S; Jiang Y; Xia B; Niu M; Li D; Zhang J; Wang S; Wei W; Liu Q; Zheng W; Zhang G; Song Y; Panga D
    Cell Physiol Biochem; 2017; 43(6):2212-2225. PubMed ID: 29069648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
    Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
    Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.